Solène Frismand
YOU?
Author Swipe
View article: Disease Progression in Multiple System Atrophy: The <scp>ASPIRE</scp> Multi‐Modal Biomarker Study
Disease Progression in Multiple System Atrophy: The <span>ASPIRE</span> Multi‐Modal Biomarker Study Open
Objective The objective of this study was to characterize changes in candidate biomarkers in early multiple system atrophy (MSA) and identify baseline predictors of faster progression. Methods This 1‐year, multicenter, prospective study as…
View article: Use and misuse of domperidone in patients living with Parkinson disease in France
Use and misuse of domperidone in patients living with Parkinson disease in France Open
Context After observing increased sudden death risk associated with domperidone use, the European Medicines Agency (EMA) imposed usage restrictions in 2014, limiting age (≤60 years), daily dose (≤30 mg/day), and duration (≤7 days). Nausea …
View article: Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: <scp>OXYDOPA</scp> Trial
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: <span>OXYDOPA</span> Trial Open
Background Among the different types of pain related to Parkinson's disease (PD), parkinsonian central pain (PCP) is the most disabling. Objectives We investigated the analgesic efficacy of two therapeutic strategies (opioid with oxycodone…
View article: Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula
Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula Open
Pain is a frequent and disabling non-motor symptom of Parkinson's Disease (PD). Yet, no treatment to date can efficiently reduce this pain. This article investigates the brain functional connectivity of PD patients with central pain and th…
View article: Autosomal Dominant <scp>MPAN</scp>: Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes
Autosomal Dominant <span>MPAN</span>: Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes Open
Background Mitochondrial membrane protein‐associated neurodegeneration (MPAN) is caused by mutations in the C19orf12 gene. MPAN typically appears in the first two decades of life and presents with progressive dystonia‐parkinsonism, lower m…
View article: Congenital mirror movements are associated with defective polymerisation of RAD51
Congenital mirror movements are associated with defective polymerisation of RAD51 Open
Background Mirror movements are involuntary movements of one hand that mirror intentional movements of the other hand. Congenital mirror movements (CMM) is a rare genetic disorder with autosomal dominant inheritance, in which mirror moveme…
View article: Optimized testing strategy for the diagnosis of GAA-<i>FGF14</i>ataxia
Optimized testing strategy for the diagnosis of GAA-<i>FGF14</i>ataxia Open
Background Dominantly inherited GAA repeat expansions in FGF14 are a common cause of spinocerebellar ataxia (GAA- FGF14 ataxia; SCA27B, late-onset). Molecular confirmation of FGF14 GAA repeat expansions has thus far mostly relied on long-r…
View article: Motion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson’s disease
Motion sickness susceptibility and visually induced motion sickness as diagnostic signs in Parkinson’s disease Open
Postural instability and loss of vestibular and somatosensory acuity can be part of the signs encountered in Parkinson’s Disease (PD). Visual dependency is described in PD. These modifications of sensory input hierarchy are predictors of m…
View article: Treatable Hyperkinetic Movement Disorders Not to Be Missed
Treatable Hyperkinetic Movement Disorders Not to Be Missed Open
Hyperkinetic movement disorders are characterized by the presence of abnormal involuntary movements, comprising most notably dystonia, chorea, myoclonus, and tremor. Possible causes are numerous, including autoimmune disorders, infections …
View article: Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing Field
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing Field Open
The early differential diagnosis of Parkinson disease and atypical parkinsonism is a major challenge. The use of single photon emission computed tomography (SPECT)/positron emission tomography (PET) molecular imaging to investigate parkins…